Additionally, targeting the iron metabolism pathway, through iron chelators, has shown promise in cancer therapies, especially in prostate and liver cancers, as STEAP3 is crucial for iron homeostasis in tumour cells [43]. This evidence concerns the gene STEAP3 and neoplasm.